BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 27665945)

  • 21. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma.
    Hui IC; Tung EK; Sze KM; Ching YP; Ng IO
    Liver Int; 2010 Jan; 30(1):65-75. PubMed ID: 19845851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive effect of sirolimus and anti-death receptor 5 agonistic antibody against hepatocellular carcinoma.
    Kawahara T; Toso C; Yamaguchi K; Cader S; Douglas DN; Nourbakhsh M; Lewis JT; Churchill TA; Yagita H; Kneteman NM
    Liver Int; 2013 Oct; 33(9):1441-8. PubMed ID: 23895107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
    Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
    Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cells.
    Krause GC; Lima KG; Haute GV; Schuster AD; Dias HB; Mesquita FC; Pedrazza L; Marczak ES; Basso BS; Velasque AC; Martha BA; Nunes FB; Donadio MV; de Oliveira JR
    Biomed Pharmacother; 2017 May; 89():358-365. PubMed ID: 28242545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1.
    Hernández-Breijo B; Monserrat J; Román ID; González-Rodríguez Á; Fernández-Moreno MD; Lobo MV; Valverde ÁM; Gisbert JP; Guijarro LG
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):568-78. PubMed ID: 23958494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of Silibinin combined with doxorubicin in hepatocellular carcinoma; an in vivo study.
    Li WG; Wang HQ
    J BUON; 2016; 21(4):917-924. PubMed ID: 27685914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-butanol fraction of Entada phaseoloides ethanol extract inhibits hepatocellular carcinoma HepG2 cell proliferation by inducing apoptosis.
    Zhang L; Huang L; Liu Q; Kuang S; Xu Q; Qin X; Fu S; Wu Q; Liu Q; Zeng Y
    J BUON; 2014; 19(2):406-11. PubMed ID: 24965399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma.
    Petrushev B; Tomuleasa C; Soritau O; Aldea M; Pop T; Susman S; Kacso G; Berindan I; Irimie A; Cristea V
    Exp Oncol; 2012; 34(1):17-24. PubMed ID: 22453143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cationic poly(amidoamine) dendrimers induced cyto-protective autophagy in hepatocellular carcinoma cells.
    Li Y; Wang S; Wang Z; Qian X; Fan J; Zeng X; Sun Y; Song P; Feng M; Ju D
    Nanotechnology; 2014 Sep; 25(36):365101. PubMed ID: 25140534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant and proapoptotic activities of Sclerocarya birrea [(A. Rich.) Hochst.] methanolic root extract on the hepatocellular carcinoma cell line HepG2.
    Armentano MF; Bisaccia F; Miglionico R; Russo D; Nolfi N; Carmosino M; Andrade PB; Valentão P; Diop MS; Milella L
    Biomed Res Int; 2015; 2015():561589. PubMed ID: 26075245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of p53 increases chemosensitivity to 5-FU in nutrient-deprived hepatocarcinoma cells by suppressing autophagy.
    Guo XL; Hu F; Zhang SS; Zhao QD; Zong C; Ye F; Guo SW; Zhang JW; Li R; Wu MC; Wei LX
    Cancer Lett; 2014 May; 346(2):278-84. PubMed ID: 24462821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.
    Sharma A; Bhat MK
    Integr Cancer Ther; 2011 Dec; 10(4):NP4-14. PubMed ID: 21994207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma.
    Zhang Y; Zhao L; Li X; Wang Y; Yao J; Wang H; Li F; Li Z; Guo Q
    Arch Toxicol; 2014 Jan; 88(1):97-107. PubMed ID: 23835921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progesterone increases epirubicin's apoptotic effects in HepG2 cells by S phase cell cycle arrest.
    Chang WT; Lin HL; Chang KL; Ker CG; Huang MC; Chen JS; Kuo KK; Chen YL; Lee KT
    Hepatogastroenterology; 2010; 57(97):107-13. PubMed ID: 20422883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
    Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
    J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
    Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
    Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells.
    Witort E; Lulli M; Carloni V; Capaccioli S
    J Chemother; 2013 Oct; 25(5):292-7. PubMed ID: 24070137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.